title: New gait stimulation devices walk the coverage line. As microprocessor-controlled devices are improved to help patients maintain freedom and function, insurers are divided on coverage.
authors.affiliation: Genentech Inc.
authors.forename: Thomas
authors.initials: T
authors.lastname: Morrow
mesh_terms: D017076:Computer-Aided Design; D020233:Gait Disorders, Neurologic / Q000209:etiology / Q000628:therapy*; D006801:Humans; D019458:Insurance Coverage; D012656:Self-Help Devices; D014481:United States